Quantcast
Home > Quotes > CRSP

CRISPR Therapeutics AG Common Shares (CRSP) Quote & Summary Data

CRSP 
$36.3
*  
0.59
1.65%
Get CRSP Alerts
*Delayed - data as of Dec. 12, 2018 9:31 ET  -  Find a broker to begin trading CRSP now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    CRSP Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 36.11 / $ 36.45
Today's High / Low
$ 36.30 / $ 36.14
Share Volume
7,904
50 Day Avg. Daily Volume
921,483
Previous Close
$ 35.71
52 Week High / Low
$ 73.90 / $ 17.399
Market Cap
1,891,647,704
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
7,904
50 Day Avg. Daily Volume:
921,483

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -2.51

Trading Range

The current last sale of $36.30 is 108.63% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 36.30 $ 73.90
 Low: $ 36.14 $ 17.399

ETFs with CRSP as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
4.15% ARK Genomic Revolution Multi-Sector ETF (ARKG) -3.19 (-10.16%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

We are a leading gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered, Regularly Interspaced Short Palindromic Repeats (CRISPR) Associated protein-9 and is a revolutionary technology for gene editing, the process of precisely altering specific sequences of genomic DNA. We are applying this technology to potentially treat a broad set of both rare and common diseases by disrupting, correcting or regulating disease-related genes. We believe that our scientific expertise, together with our gene editing approach, may enable an entirely new class of highly effective and potentially curative treatments for patients for whom current biopharmaceutical approaches have had limited success. Our most advanced programs target beta-thalassemia and sickle cell disease, two hemoglobinopathies that have high unmet medical need.  ... More ...  


Risk Grade

Where does CRSP fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 36.14
Open Date:
Dec. 12, 2018
Close Price:
$ 35.71
Close Date:
Dec. 11, 2018

Consensus Recommendation

Analyst Info